Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00840125
Recruitment Status : Completed
First Posted : February 10, 2009
Last Update Posted : October 30, 2012
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2010
Actual Study Completion Date : August 2011